• Products
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Non Convertible Debentures
    Sovereign Gold Bond
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    SipIt
    MTF
  • Platform
    Trading Platforms
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Trade From Charts
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Trading Platforms
    Features and Tools
    Calculators
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Trade From Charts
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Stock Research Recommendations
    MTF Stock Recommendations
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Stock Research Recommendations
    MTF Stock Recommendations
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
  • Market
    Market Movers
    Share Market Today
    Top Gainers
    Top Losers
    Stocks
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Tata Capital IPO
    Amanta Healthcare IPO
    Quarterly Results
    Jindal Steel's Q1 FY 2025-26 Quarterly Results
    SRI LOTUS DEVLPRS N RTY L's Q1 FY 2025-26 Quarterly Results
    Aeroflex Neu's Q1 FY 2025-26 Quarterly Results
    PVP Ventures' Q1 FY 2025-26 Quarterly Results
    Market Movers
    Stocks
    Indices
    Mutual Funds
    IPO
    Quarterly Results
    Share Market Today
    Top Gainers
    Top Losers
    52 Week High
    52 Week Low
    Volume Shockers
    Large Cap
    Mid Cap
    Small Cap
    State Bank of India
    Reliance Industries Ltd
    HDFC Bank Ltd
    Infosys Ltd
    Tata Consultancy Services Ltd
    Hindustan Unilever Ltd
    ITC Ltd
    IRCTC
    NSE
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    BSE
    Sensex
    BSE Bankex
    BSE Small Cap
    BSE Mid Cap
    BSE 100
    Indian Indices
    Global Indices
    Gift Nifty
    S&P
    Nikkei Index
    Hong Kong Index
    KOSPI Index
    Global Indices
    AMC's
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    Schemes
    Parag Parikh Flexi Cap
    SBI Small Cap Fund
    SBI Contra Fund
    Nippon Small Cap Fund
    ICICI Pru Technology Fund
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Tata Capital IPO
    Amanta Healthcare IPO
    Sugs Lloyd Ltd
    Snehaa Organics Ltd
    Abril Paper Tech Ltd
    Rachit Prints Ltd
    Amanta Healthcare Ltd
    Optivalue Tek Consulting Ltd
    Goel Construction Company Ltd
    boAt IPO
    Jindal Steel's Q1 FY 2025-26 Quarterly Results
    SRI LOTUS DEVLPRS N RTY L's Q1 FY 2025-26 Quarterly Results
    Aeroflex Neu's Q1 FY 2025-26 Quarterly Results
    PVP Ventures' Q1 FY 2025-26 Quarterly Results
    NDR INVIT Trust's Q1 FY 2025-26 Quarterly Results
    Jaiprakash Associates' Q1 FY 2025-26 Quarterly Results
    Alps Industries' Q1 FY 2025-26 Quarterly Results
    Brightcom Group's Q1 FY 2025-26 Quarterly Results
    Visa Steel's Q1 FY 2025-26 Quarterly Results
    Coffee Day Enterprises' Q1 FY 2025-26 Quarterly Results
    Supreme Holdings & Hospitality's Q1 FY 2025-26 Quarterly Results
    Kavveri Defence & Wireless Technologies' Q1 FY 2025-26 Quarterly Results
  • Learn
    Stockshaala
    Basics of Stock Market
    Introduction to Fundamental Analysis
    Introduction to Technical Analysis
    Derivatives, Risk management & Option Trading Strategies
    Personal Finance
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Stockshaala
    Resource
    Investing Guide
    Events
    Basics of Stock Market
    Introduction to Fundamental Analysis
    Introduction to Technical Analysis
    Derivatives, Risk management & Option Trading Strategies
    Personal Finance
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement
  • News

Insightful Analysis: Unveiling the Indegene IPO

  •  4 min read
  •  6,576
  • Updated 22 May 2024
Insightful Analysis: Unveiling the Indegene IPO

Key Highlights:

  • Indegene Ltd, a life sciences commercialisation company, has come out with its IPO with an issue size of Rs 1841.76 crores

  • The book-building IPO consists of fresh issues and offer for sale

  • Over the years, the company has recorded impressive returns on equity, total assets and net revenues


As Indian stock exchanges, the Bombay Stock Exchange (BSE) and the National Stock Exchange (BSE), touch new highs, investors’ confidence in the Indian growth story is evident. Several companies are looking to cash in on this optimism by going public, and Indegene Ltd is one of them.

Founded in 1998, Indegene Ltd is a life sciences commercialisation company. It offers digital-led commercialisation services for the life sciences industry, including medical device companies and biopharma. With its healthcare domain expertise and technological prowess, the company assists life science companies in clinical trials, aids in launching their products in the market and supports their safety and regulatory operations. Enabling life science and healthcare institutions to be future-ready, the company has a global presence with 17 offices and 5000+ worldwide team members.

Indegene Ltd has come out with its IPO. The table below captures other key details of the IPO:

Issue size Rs 1841.76 crores
Face value
Rs 2
Minimum investment
Rs 14,916
Total shares offered
40,746,891
Fresh issue
1,68,14,159
Offer for sale
23, 932,732
Issue price
Rs 430 - Rs 452
Lot size
33
IPO type
Book building
Listing on
BSE and NSE
Listing date
13th May

The company plans to use the funds obtained from fresh issues to:

  • Fund its capex requirements
  • Repay and prepay debt of its subsidiary, ILSL Holdings
  • Meet general corporate needs

Indegene boasts of impressive financials. The table below captures some of the key financials of the company that show its impressive performance across different financial years:

Particulars FY 23 FY 22 FY 21
Net revenues (in crores)
2,306.13
1,664.61
966.27
Profit after tax (in crores)
266.10
164.76
149.41
PAT margins
11.54%
9.90%
15.46%
Total assets (in crores)
2,203.87
1,353.47
596.04
Return on equity
25.02%
21.57%
46.04%
Earnings per share
11.97
7.46
8.74

The financials of the company reflect certain key things. These include:

  • A significant jump in net profits along with an impressive return on equity. A high return on equity shows that the company has been able to successfully convert its equity financing into profits.

  • The company's total assets and net revenues have considerably jumped. This reflects the company's acquisition of more resources with time and its effective management of expenses.

The life sciences industry, which includes biopharma and medical device companies, is a thriving sector. Its combined sales stood at USD 1.8 trillion in 2023 and are projected to reach USD 2.1 trillion by 2026. A growing population coupled with the increasing prevalence of chronic is a strong indicator of the sector's potential for growth in the coming days, offering a promising outlook for investors.

The company's unique business model and virtual monopoly position it for bright prospects in the future. Along with its strong domain expertise, its global delivery model can help it sustain its growth momentum in the future.

Summing it up

Before subscribing to a company's IPO, it's crucial for you to be well aware of the company's strengths and risks. Read the draft red herring prospectus for a complete overview and ensure you have holistic knowledge about your financial goals and risk appetite before subscribing.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI prescribed Combined Risk Disclosure Document prior to investing. Brokerage will not exceed SEBI prescribed limit.

Source: RHP

FAQs

The issue size of Indegene IPO is Rs 1841.76 crores.

Yes, Indegene is a profitable company. Its profit after tax stood at Rs 266.10 crores in FY 23 from Rs 164.76 crores in FY 22, registering a growth of approximately 61.5%.

Did you enjoy this article?

0 people liked this article.

What could we have done to make this article better?

Open Your Demat Account Now!
+91 -

Open Your Demat Account Now!
+91 -